{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:36:23Z","timestamp":1789050983056,"version":"build-2803163510"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research council of Norway","award":["275190"],"award-info":[{"award-number":["275190"]}]},{"name":"Research council of Norway","award":["273646"],"award-info":[{"award-number":["273646"]}]},{"name":"Research council of Norway","award":["273646"],"award-info":[{"award-number":["273646"]}]},{"name":"Research council of Norway","award":["273646"],"award-info":[{"award-number":["273646"]}]},{"name":"Research council of Norway","award":["275190"],"award-info":[{"award-number":["275190"]}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["790507"],"award-info":[{"award-number":["790507"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"crossref","award":["790507"],"award-info":[{"award-number":["790507"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics &amp; Antimicro. Prot."],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Enterococci are commensals of human and other animals\u2019 gastrointestinal tracts. Only making up a small part of the microbiota, they have not played a significant role in research, until the 1980s. Although the exact year is variable according to different geographical areas, this was the decade when vancomycin-resistant enterococci (VRE) were discovered and since then their role as causative agents of human infections has increased. <jats:italic>Enterococcus faecium<\/jats:italic> is on the WHO\u2019s list of \u201cbacteria for which new antibiotics are urgently needed,\u201d and with no new antibiotics in development, the situation is desperate. In this review, different aspects of VRE are outlined, including the mortality caused by VRE, antibiotic resistance profiles, animal-modeling efforts, and virulence. In addition, the limitations of current antibiotic treatments for VRE and prospective new treatments, such as bacteriocins, are reviewed.<\/jats:p>","DOI":"10.1007\/s12602-019-09618-6","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T23:02:22Z","timestamp":1574463742000},"page":"1203-1217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution"],"prefix":"10.1007","volume":"12","author":[{"given":"Ingvild S.","family":"Reinseth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill V.","family":"Ovchinnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne H.","family":"T\u00f8nnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Carlsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7661-5501","authenticated-orcid":false,"given":"Dzung B.","family":"Diep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"issue":"2","key":"9618_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0732-8893(00)00130-9","volume":"37","author":"FM Aarestrup","year":"2000","unstructured":"Aarestrup FM, Agerso Y, Gerner-Smidt P, Madsen M, Jensen LB (2000) Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagn Microbiol Infect Dis 37(2):127\u2013137","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"9618_CR2","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1128\/JCM.00195-06","volume":"44","author":"M Abele-Horn","year":"2006","unstructured":"Abele-Horn M, Vogel U, Klare I, Konstabel C, Trabold R, Kurihara R, Witte W, Kreth W, Schlegel PG, Claus H (2006) Molecular epidemiology of hospital-acquired vancomycin-resistant enterococci. J Clin Microbiol 44(11):4009\u20134013. https:\/\/doi.org\/10.1128\/JCM.00195-06","journal-title":"J Clin Microbiol"},{"issue":"7","key":"9618_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1542\/hpeds.2015-0196","volume":"6","author":"DJ Adams","year":"2016","unstructured":"Adams DJ, Eberly MD, Goudie A, Nylund CM (2016) Rising vancomycin-resistant Enterococcus infections in hospitalized children in the United States. Hosp Pediatr 6(7):404\u2013411. https:\/\/doi.org\/10.1542\/hpeds.2015-0196","journal-title":"Hosp Pediatr"},{"issue":"7","key":"9618_CR4","first-page":"829","volume":"66","author":"N Akhtar","year":"2016","unstructured":"Akhtar N, Sultan F, Nizamuddin S, Zafar W (2016) Risk factors and clinical outcomes for vancomycin-resistant Enterococcus bacteraemia in hospitalised cancer patients in Pakistan: a case-control study. J Pak Med Assoc 66(7):829\u2013836","journal-title":"J Pak Med Assoc"},{"issue":"22","key":"9618_CR5","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1038\/sj.emboj.7600449","volume":"23","author":"Y Akiyama","year":"2004","unstructured":"Akiyama Y, Kanehara K, Ito K (2004) RseP (YaeL), an Escherichia coli RIP protease, cleaves transmembrane sequences. EMBO J 23(22):4434\u20134442. https:\/\/doi.org\/10.1038\/sj.emboj.7600449","journal-title":"EMBO J"},{"key":"9618_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ijbiomac.2018.05.002","volume":"116","author":"D Ankaiah","year":"2018","unstructured":"Ankaiah D, Palanichamy E, Antonyraj CB, Ayyanna R, Perumal V, Ahamed SIB, Arul V (2018) Cloning, overexpression, purification of bacteriocin enterocin-B and structural analysis, interaction determination of enterocin-a, B against pathogenic bacteria and human cancer cells. Int J Biol Macromol 116:502\u2013512. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.05.002","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"9618_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1469-0691.2010.03214.x10.1111\/j.1198-743X.2010.03214.x","volume":"16","author":"CA Arias","year":"2010","unstructured":"Arias CA, Contreras GA, Murray BE (2010) Management of multidrug-resistant enterococcal infections. Clin Microbiol Infect 16(6):555\u2013562. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03214.x10.1111\/j.1198-743X.2010.03214.x","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"9618_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","volume":"10","author":"CA Arias","year":"2012","unstructured":"Arias CA, Murray BE (2012) The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10(4):266\u2013278. https:\/\/doi.org\/10.1038\/nrmicro2761","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"9618_CR9","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1056\/NEJMoa1011138","volume":"365","author":"CA Arias","year":"2011","unstructured":"Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz L, Tran TT, Rincon S, Barbu EM, Reyes J, Roh JH, Lobos E, Sodergren E, Pasqualini R, Arap W, Quinn JP, Shamoo Y, Murray BE, Weinstock GM (2011) Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 365(10):892\u2013900. https:\/\/doi.org\/10.1056\/NEJMoa1011138","journal-title":"N Engl J Med"},{"issue":"1","key":"9618_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40121-016-0103-4","volume":"5","author":"KD Brade","year":"2016","unstructured":"Brade KD, Rybak JM, Rybak MJ (2016) Oritavancin: a new lipoglycopeptide antibiotic in the treatment of Gram-positive infections. Infect Dis Ther 5(1):1\u201315. https:\/\/doi.org\/10.1007\/s40121-016-0103-4","journal-title":"Infect Dis Ther"},{"issue":"6","key":"9618_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1472-765X.2010.02948.x","volume":"51","author":"AM Brand","year":"2010","unstructured":"Brand AM, de Kwaadsteniet M, Dicks LM (2010) The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice. Lett Appl Microbiol 51(6):645\u2013649. https:\/\/doi.org\/10.1111\/j.1472-765X.2010.02948.x","journal-title":"Lett Appl Microbiol"},{"issue":"7214","key":"9618_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature07250","volume":"455","author":"K Brandl","year":"2008","unstructured":"Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, Schnabl B, DeMatteo RP, Pamer EG (2008) Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455(7214):804\u2013807. https:\/\/doi.org\/10.1038\/nature07250","journal-title":"Nature"},{"issue":"8","key":"9618_CR13","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1084\/jem.20070563","volume":"204","author":"K Brandl","year":"2007","unstructured":"Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG (2007) MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J Exp Med 204(8):1891\u20131900. https:\/\/doi.org\/10.1084\/jem.20070563","journal-title":"J Exp Med"},{"issue":"4","key":"9618_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0092-8674(00)80675-3","volume":"100","author":"MS Brown","year":"2000","unstructured":"Brown MS, Ye J, Rawson RB, Goldstein JL (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100(4):391\u2013398","journal-title":"Cell"},{"issue":"11","key":"9618_CR15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nri3535","volume":"13","author":"CG Buffie","year":"2013","unstructured":"Buffie CG, Pamer EG (2013) Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 13(11):790\u2013801. https:\/\/doi.org\/10.1038\/nri3535","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"9618_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005132","volume":"11","author":"S Caballero","year":"2015","unstructured":"Caballero S, Carter R, Ke X, Susac B, Leiner IM, Kim GJ, Miller L, Ling L, Manova K, Pamer EG (2015) Distinct but spatially overlapping intestinal niches for vancomycin-resistant Enterococcus faecium and carbapenem-resistant Klebsiella pneumoniae. PLoS Pathog 11(9):e1005132. https:\/\/doi.org\/10.1371\/journal.ppat.1005132","journal-title":"PLoS Pathog"},{"issue":"3","key":"9618_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijantimicag.2016.11.016","volume":"49","author":"DL Caly","year":"2017","unstructured":"Caly DL, Chevalier M, Flahaut C, Cudennec B, Al Atya AK, Chataigne G, D'Inca R, Auclair E, Drider D (2017) The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity. Int J Antimicrob Agents 49(3):282\u2013289. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.11.016","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"9618_CR18","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1128\/AAC.00526-13","volume":"57","author":"AM Casapao","year":"2013","unstructured":"Casapao AM, Kullar R, Davis SL, Levine DP, Zhao JJ, Potoski BA, Goff DA, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ (2013) Multicenter study of high-dose daptomycin for treatment of enterococcal infections. Antimicrob Agents Chemother 57(9):4190\u20134196. https:\/\/doi.org\/10.1128\/AAC.00526-13","journal-title":"Antimicrob Agents Chemother"},{"key":"9618_CR19","doi-asserted-by":"publisher","unstructured":"Cebri\u00e1n R, Rodr\u00edguez-Cabezas ME, Mart\u00edn-Escolano R, Rubi\u00f1o S, Garrido-Barros M, Montalb\u00e1n-L\u00f3pez M, Rosales MJ, S\u00e1nchez-Moreno M, Valdivia E, Mart\u00ednez-Bueno M, Mar\u00edn C, Galvez J, Maqueda M (2019) Preclinical studies of toxicity and safety of the AS-48 bacteriocin. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2019.06.003","DOI":"10.1016\/j.jare.2019.06.003"},{"issue":"3","key":"9618_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00284-017-1375-y","volume":"75","author":"H Chi","year":"2018","unstructured":"Chi H, Holo H (2018) Synergistic antimicrobial activity between the broad spectrum bacteriocin garvicin KS and nisin, farnesol and polymyxin B against Gram-positive and Gram-negative bacteria. Curr Microbiol 75(3):272\u2013277. https:\/\/doi.org\/10.1007\/s00284-017-1375-y","journal-title":"Curr Microbiol"},{"key":"9618_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12879-014-0687-9","volume":"14","author":"YC Chuang","year":"2014","unstructured":"Chuang YC, Wang JT, Lin HY, Chang SC (2014) Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. BMC Infect Dis 14:687. https:\/\/doi.org\/10.1186\/s12879-014-0687-9","journal-title":"BMC Infect Dis"},{"issue":"11","key":"9618_CR22","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1128\/aem.63.11.4321-4330.1997","volume":"63","author":"LM Cintas","year":"1997","unstructured":"Cintas LM, Casaus P, Havarstein LS, Hernandez PE, Nes IF (1997) Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum. Appl Environ Microbiol 63(11):4321\u20134330","journal-title":"Appl Environ Microbiol"},{"issue":"5","key":"9618_CR23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1590\/S0074-02762013000500009","volume":"108","author":"CB Comerlato","year":"2013","unstructured":"Comerlato CB, Resende MC, Caierao J, d'Azevedo PA (2013) Presence of virulence factors in Enterococcus faecalis and Enterococcus faecium susceptible and resistant to vancomycin. Mem Inst Oswaldo Cruz 108(5):590\u2013595","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"9618_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/1574-6976.12046","volume":"38","author":"LC Cook","year":"2014","unstructured":"Cook LC, Federle MJ (2014) Peptide pheromone signaling in Streptococcus and Enterococcus. FEMS Microbiol Rev 38(3):473\u2013492. https:\/\/doi.org\/10.1111\/1574-6976.12046","journal-title":"FEMS Microbiol Rev"},{"issue":"6","key":"9618_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1111\/mmi.12645","volume":"92","author":"PD Cotter","year":"2014","unstructured":"Cotter PD (2014) An \u2018Upp\u2019-turn in bacteriocin receptor identification. Mol Microbiol 92(6):1159\u20131163. https:\/\/doi.org\/10.1111\/mmi.12645","journal-title":"Mol Microbiol"},{"issue":"10","key":"9618_CR26","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrmicro1273","volume":"3","author":"PD Cotter","year":"2005","unstructured":"Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3(10):777\u2013788. https:\/\/doi.org\/10.1038\/nrmicro1273","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"9618_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro2937","volume":"11","author":"PD Cotter","year":"2013","unstructured":"Cotter PD, Ross RP, Hill C (2013) Bacteriocins\u2014a viable alternative to antibiotics? Nat Rev Microbiol 11(2):95\u2013105. https:\/\/doi.org\/10.1038\/nrmicro2937","journal-title":"Nat Rev Microbiol"},{"issue":"10","key":"9618_CR28","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.clinthera.2010.09.008","volume":"32","author":"CW Crank","year":"2010","unstructured":"Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J (2010) Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: a retrospective, multicenter, cohort study. Clin Ther 32(10):1713\u20131719. https:\/\/doi.org\/10.1016\/j.clinthera.2010.09.008","journal-title":"Clin Ther"},{"issue":"1","key":"9618_CR29","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1038\/s41598-018-23437-9","volume":"8","author":"L Crouzet","year":"2018","unstructured":"Crouzet L, Derrien M, Cherbuy C, Plancade S, Foulon M, Chalin B, van Hylckama Vlieg JET, Grompone G, Rigottier-Gois L, Serror P (2018) Lactobacillus paracasei CNCM I-3689 reduces vancomycin-resistant Enterococcus persistence and promotes Bacteroidetes resilience in the gut following antibiotic challenge. Sci Rep 8(1):5098. https:\/\/doi.org\/10.1038\/s41598-018-23437-9","journal-title":"Sci Rep"},{"issue":"7","key":"9618_CR30","doi-asserted-by":"publisher","first-page":"e1003388","DOI":"10.1371\/journal.ppat.1003388","volume":"9","author":"AJ Darwin","year":"2013","unstructured":"Darwin AJ (2013) Stress relief during host infection: the phage shock protein response supports bacterial virulence in various ways. PLoS Pathog 9(7):e1003388. https:\/\/doi.org\/10.1371\/journal.ppat.1003388","journal-title":"PLoS Pathog"},{"issue":"1","key":"9618_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1365-2958.1999.01324.x","volume":"32","author":"AJ Darwin","year":"1999","unstructured":"Darwin AJ, Miller VL (1999) Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis. Mol Microbiol 32(1):51\u201362","journal-title":"Mol Microbiol"},{"issue":"1","key":"9618_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1472-765X.2008.02488.x","volume":"48","author":"M De Kwaadsteniet","year":"2009","unstructured":"De Kwaadsteniet M, Doeschate KT, Dicks LM (2009) Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus. Lett Appl Microbiol 48(1):65\u201370. https:\/\/doi.org\/10.1111\/j.1472-765X.2008.02488.x","journal-title":"Lett Appl Microbiol"},{"issue":"2","key":"9618_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12602-009-9017-8","volume":"2","author":"M de Kwaadsteniet","year":"2010","unstructured":"de Kwaadsteniet M, van Reenen CA, Dicks LM (2010) Evaluation of nisin F in the treatment of subcutaneous skin infections, as monitored by using a bioluminescent strain of Staphylococcus aureus. Probiotics Antimicrob Proteins 2(2):61\u201365. https:\/\/doi.org\/10.1007\/s12602-009-9017-8","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"10","key":"9618_CR34","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1128\/AAC.01473-15","volume":"59","author":"LM Deshpande","year":"2015","unstructured":"Deshpande LM, Ashcraft DS, Kahn HP, Pankey G, Jones RN, Farrell DJ, Mendes RE (2015) Detection of a new cfr-like gene, cfr(B), in Enterococcus faecium isolates recovered from human specimens in the United States as part of the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 59(10):6256\u20136261. https:\/\/doi.org\/10.1128\/AAC.01473-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"9618_CR35","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1073\/pnas.0608775104","volume":"104","author":"DB Diep","year":"2007","unstructured":"Diep DB, Skaugen M, Salehian Z, Holo H, Nes IF (2007) Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc Natl Acad Sci U S A 104(7):2384\u20132389. https:\/\/doi.org\/10.1073\/pnas.0608775104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"9618_CR36","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1128\/AAC.47.7.2307-2309.2003","volume":"47","author":"J Dina","year":"2003","unstructured":"Dina J, Malbruny B, Leclercq R (2003) Nonsense mutations in the lsa-like gene in Enterococcus faecalis isolates susceptible to lincosamides and Streptogramins A. Antimicrob Agents Chemother 47(7):2307\u20132309","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"9618_CR37","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1128\/JCM.00850-06","volume":"44","author":"TE Dobbs","year":"2006","unstructured":"Dobbs TE, Patel M, Waites KB, Moser SA, Stamm AM, Hoesley CJ (2006) Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center. J Clin Microbiol 44(9):3368\u20133370. https:\/\/doi.org\/10.1128\/JCM.00850-06","journal-title":"J Clin Microbiol"},{"issue":"9","key":"9618_CR38","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1016\/j.bbamem.2009.05.003","volume":"1788","author":"O Domenech","year":"2009","unstructured":"Domenech O, Francius G, Tulkens PM, Van Bambeke F, Dufrene Y, Mingeot-Leclercq MP (2009) Interactions of oritavancin, a new lipoglycopeptide derived from vancomycin, with phospholipid bilayers: effect on membrane permeability and nanoscale lipid membrane organization. Biochim Biophys Acta 1788(9):1832\u20131840. https:\/\/doi.org\/10.1016\/j.bbamem.2009.05.003","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"9618_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1086\/422002","volume":"39","author":"CJ Donskey","year":"2004","unstructured":"Donskey CJ (2004) The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin Infect Dis 39(2):219\u2013226. https:\/\/doi.org\/10.1086\/422002","journal-title":"Clin Infect Dis"},{"issue":"5","key":"9618_CR40","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1086\/315428","volume":"181","author":"CJ Donskey","year":"2000","unstructured":"Donskey CJ, Hanrahan JA, Hutton RA, Rice LB (2000) Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 181(5):1830\u20131833. https:\/\/doi.org\/10.1086\/315428","journal-title":"J Infect Dis"},{"issue":"3","key":"9618_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.diagmicrobio.2007.10.006","volume":"60","author":"H Dupont","year":"2008","unstructured":"Dupont H, Vael C, Muller-Serieys C, Chosidow D, Mantz J, Marmuse JP, Andremont A, Goossens H, Desmonts JM (2008) Prospective evaluation of virulence factors of enterococci isolated from patients with peritonitis: impact on outcome. Diagn Microbiol Infect Dis 60(3):247\u2013253. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2007.10.006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"9618_CR42","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/clinids\/23.6.1234","volume":"23","author":"MB Edmond","year":"1996","unstructured":"Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP (1996) Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 23(6):1234\u20131239","journal-title":"Clin Infect Dis"},{"issue":"9","key":"9618_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185279","volume":"12","author":"B Ekblad","year":"2017","unstructured":"Ekblad B, Nissen-Meyer J, Kristensen T (2017) Whole-genome sequencing of mutants with increased resistance against the two-peptide bacteriocin plantaricin JK reveals a putative receptor and potential docking site. PLoS One 12(9):e0185279. https:\/\/doi.org\/10.1371\/journal.pone.0185279","journal-title":"PLoS One"},{"issue":"14","key":"9618_CR44","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1101\/gad.1440606","volume":"20","author":"CD Ellermeier","year":"2006","unstructured":"Ellermeier CD, Losick R (2006) Evidence for a novel protease governing regulated intramembrane proteolysis and resistance to antimicrobial peptides in Bacillus subtilis. Genes Dev 20(14):1911\u20131922. https:\/\/doi.org\/10.1101\/gad.1440606","journal-title":"Genes Dev"},{"issue":"5","key":"9618_CR45","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1128\/AAC.41.5.931","volume":"41","author":"B Fantin","year":"1997","unstructured":"Fantin B, Leclercq R, Garry L, Carbon C (1997) Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob Agents Chemother 41(5):931\u2013935","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9618_CR46","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/IAI.05964-11","volume":"80","author":"KL Frank","year":"2012","unstructured":"Frank KL, Barnes AM, Grindle SM, Manias DA, Schlievert PM, Dunny GM (2012) Use of recombinase-based in vivo expression technology to characterize Enterococcus faecalis gene expression during infection identifies in vivo-expressed antisense RNAs and implicates the protease Eep in pathogenesis. Infect Immun 80(2):539\u2013549. https:\/\/doi.org\/10.1128\/IAI.05964-11","journal-title":"Infect Immun"},{"issue":"22","key":"9618_CR47","doi-asserted-by":"publisher","first-page":"6854","DOI":"10.1128\/AEM.02284-14","volume":"80","author":"C Gabrielsen","year":"2014","unstructured":"Gabrielsen C, Brede DA, Nes IF, Diep DB (2014) Circular bacteriocins: biosynthesis and mode of action. Appl Environ Microbiol 80(22):6854\u20136862. https:\/\/doi.org\/10.1128\/AEM.02284-14","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"9618_CR48","doi-asserted-by":"publisher","first-page":"6844","DOI":"10.1128\/AAC.01519-15","volume":"59","author":"CV Garcia De Gonzalo","year":"2015","unstructured":"Garcia De Gonzalo CV, Denham EL, Mars RA, Stulke J, van der Donk WA, van Dijl JM (2015) The phosphoenolpyruvate:sugar phosphotransferase system is involved in sensitivity to the glucosylated bacteriocin sublancin. Antimicrob Agents Chemother 59(11):6844\u20136854. https:\/\/doi.org\/10.1128\/AAC.01519-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"17","key":"9618_CR49","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1073\/pnas.1620432114","volume":"114","author":"CE Graham","year":"2017","unstructured":"Graham CE, Cruz MR, Garsin DA, Lorenz MC (2017) Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc Natl Acad Sci U S A 114(17):4507\u20134512. https:\/\/doi.org\/10.1073\/pnas.1620432114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"9618_CR50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/08998280.2006.11928154","volume":"19","author":"ND Greer","year":"2006","unstructured":"Greer ND (2006) Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics. Proc (Bayl Univ Med Cent) 19(2):155\u2013161","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"9618_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2217\/fmb-2016-0113","volume":"12","author":"H Hanchi","year":"2017","unstructured":"Hanchi H, Hammami R, Gingras H, Kourda R, Bergeron MG, Ben Hamida J, Ouellette M, Fliss I (2017) Inhibition of MRSA and of Clostridium difficile by durancin 61A: synergy with bacteriocins and antibiotics. Future Microbiol 12:205\u2013212. https:\/\/doi.org\/10.2217\/fmb-2016-0113","journal-title":"Future Microbiol"},{"key":"9618_CR52","doi-asserted-by":"publisher","unstructured":"Hayes K, Cotter L, O'Halloran F (2019) In-vitro synergistic activity of erythromycin and nisin against clinical Group B Streptococcus isolates. J Appl Microbiol. https:\/\/doi.org\/10.1111\/jam.14400","DOI":"10.1111\/jam.14400"},{"issue":"6","key":"9618_CR53","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/tid.12612","volume":"18","author":"M Hefazi","year":"2016","unstructured":"Hefazi M, Damlaj M, Alkhateeb HB, Partain DK, Patel R, Razonable RR, Gastineau DA, Al-Kali A, Hashmi SK, Hogan WJ, Litzow MR, Patnaik MM (2016) Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. Transpl Infect Dis 18(6):913\u2013920. https:\/\/doi.org\/10.1111\/tid.12612","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"9618_CR54","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1469-0691.2010.03226.x","volume":"16","author":"K Hegstad","year":"2010","unstructured":"Hegstad K, Mikalsen T, Coque TM, Werner G, Sundsfjord A (2010) Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin Microbiol Infect 16(6):541\u2013554. https:\/\/doi.org\/10.1111\/j.1469-0691.2010.03226.x","journal-title":"Clin Microbiol Infect"},{"issue":"22","key":"9618_CR55","doi-asserted-by":"publisher","first-page":"8233","DOI":"10.1128\/JB.01205-07","volume":"189","author":"E Heikens","year":"2007","unstructured":"Heikens E, Bonten MJ, Willems RJ (2007) Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 189(22):8233\u20138240. https:\/\/doi.org\/10.1128\/JB.01205-07","journal-title":"J Bacteriol"},{"key":"9618_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2180-9-19","volume":"9","author":"E Heikens","year":"2009","unstructured":"Heikens E, Leendertse M, Wijnands LM, van Luit-Asbroek M, Bonten MJ, van der Poll T, Willems RJ (2009) Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice. BMC Microbiol 9:19. https:\/\/doi.org\/10.1186\/1471-2180-9-19","journal-title":"BMC Microbiol"},{"issue":"22","key":"9618_CR57","doi-asserted-by":"publisher","first-page":"8321","DOI":"10.1128\/JB.00664-07","volume":"189","author":"AP Hendrickx","year":"2007","unstructured":"Hendrickx AP, van Wamel WJ, Posthuma G, Bonten MJ, Willems RJ (2007) Five genes encoding surface-exposed LPXTG proteins are enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates. J Bacteriol 189(22):8321\u20138332. https:\/\/doi.org\/10.1128\/JB.00664-07","journal-title":"J Bacteriol"},{"issue":"3","key":"9618_CR58","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1128\/AAC.49.3.1127-1134.2005","volume":"49","author":"DL Higgins","year":"2005","unstructured":"Higgins DL, Chang R, Debabov DV, Leung J, Wu T, Krause KM, Sandvik E, Hubbard JM, Kaniga K, Schmidt DE Jr, Gao Q, Cass RT, Karr DE, Benton BM, Humphrey PP (2005) Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 49(3):1127\u20131134. https:\/\/doi.org\/10.1128\/AAC.49.3.1127-1134.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9618_CR59","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.mib.2012.01.001","volume":"15","author":"TD Ho","year":"2012","unstructured":"Ho TD, Ellermeier CD (2012) Extra cytoplasmic function sigma factor activation. Curr Opin Microbiol 15(2):182\u2013188. https:\/\/doi.org\/10.1016\/j.mib.2012.01.001","journal-title":"Curr Opin Microbiol"},{"issue":"11","key":"9618_CR60","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1139\/cjm-2015-0446","volume":"61","author":"H Ispirli","year":"2015","unstructured":"Ispirli H, Demirbas F, Dertli E (2015) Characterization of functional properties of Enterococcus faecium strains isolated from human gut. Can J Microbiol 61(11):861\u2013870. https:\/\/doi.org\/10.1139\/cjm-2015-0446","journal-title":"Can J Microbiol"},{"issue":"11","key":"9618_CR61","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1128\/aem.66.11.4798-4802.2000","volume":"66","author":"L Johnsen","year":"2000","unstructured":"Johnsen L, Fimland G, Eijsink V, Nissen-Meyer J (2000) Engineering increased stability in the antimicrobial peptide pediocin PA-1. Appl Environ Microbiol 66(11):4798\u20134802. https:\/\/doi.org\/10.1128\/aem.66.11.4798-4802.2000","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"9618_CR62","doi-asserted-by":"publisher","first-page":"ofv156","DOI":"10.1093\/ofid\/ofv156","volume":"2","author":"JA Johnson","year":"2015","unstructured":"Johnson JA, Feeney ER, Kubiak DW, Corey GR (2015) Prolonged use of oritavancin for vancomycin-resistant Enterococcus faecium prosthetic valve endocarditis. Open Forum Infect Dis 2(4):ofv156. https:\/\/doi.org\/10.1093\/ofid\/ofv156","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"9618_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1574-6976.2007.00091.x","volume":"32","author":"S Jordan","year":"2008","unstructured":"Jordan S, Hutchings MI, Mascher T (2008) Cell envelope stress response in Gram-positive bacteria. FEMS Microbiol Rev 32(1):107\u2013146. https:\/\/doi.org\/10.1111\/j.1574-6976.2007.00091.x","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"9618_CR64","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1086\/659152","volume":"32","author":"M Kamboj","year":"2011","unstructured":"Kamboj M, Cohen N, Gilhuley K, Babady NE, Seo SK, Sepkowitz KA (2011) Emergence of daptomycin-resistant VRE: experience of a single institution. Infect Control Hosp Epidemiol 32(4):391\u2013394. https:\/\/doi.org\/10.1086\/659152","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1\u20132","key":"9618_CR65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0378-1119(01)00823-X","volume":"281","author":"K Kanehara","year":"2001","unstructured":"Kanehara K, Akiyama Y, Ito K (2001) Characterization of the yaeL gene product and its S2P-protease motifs in Escherichia coli. Gene 281(1\u20132):71\u201379","journal-title":"Gene"},{"issue":"1","key":"9618_CR66","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bjid.2014.09.010","volume":"19","author":"A Kara","year":"2015","unstructured":"Kara A, Devrim I, Bayram N, Katipoglu N, Kiran E, Oruc Y, Demiray N, Apa H, Gulfidan G (2015) Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Braz J Infect Dis 19(1):58\u201361. https:\/\/doi.org\/10.1016\/j.bjid.2014.09.010","journal-title":"Braz J Infect Dis"},{"key":"9618_CR67","unstructured":"Kristich CJ, Rice LB, Arias CA (2014) Enterococcal infection\u2014treatment and antibiotic resistance. In: Gilmore MS, Clewell DB, Ike Y, Shankar N (eds) Enterococci: from commensals to leading causes of drug resistant infection, Boston. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK190424\/"},{"issue":"9","key":"9618_CR68","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1128\/JB.00259-12","volume":"194","author":"MM Lam","year":"2012","unstructured":"Lam MM, Seemann T, Bulach DM, Gladman SL, Chen H, Haring V, Moore RJ, Ballard S, Grayson ML, Johnson PD, Howden BP, Stinear TP (2012) Comparative analysis of the first complete Enterococcus faecium genome. J Bacteriol 194(9):2334\u20132341. https:\/\/doi.org\/10.1128\/JB.00259-12","journal-title":"J Bacteriol"},{"issue":"1","key":"9618_CR69","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1371\/journal.ppat.0030007","volume":"3","author":"HL Leavis","year":"2007","unstructured":"Leavis HL, Willems RJ, van Wamel WJ, Schuren FH, Caspers MP, Bonten MJ (2007) Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog 3(1):e7. https:\/\/doi.org\/10.1371\/journal.ppat.0030007","journal-title":"PLoS Pathog"},{"issue":"7","key":"9618_CR70","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/605609","volume":"200","author":"M Leendertse","year":"2009","unstructured":"Leendertse M, Heikens E, Wijnands LM, van Luit-Asbroek M, Teske GJ, Roelofs JJ, Bonten MJ, van der Poll T, Willems RJ (2009) Enterococcal surface protein transiently aggravates Enterococcus faecium-induced urinary tract infection in mice. J Infect Dis 200(7):1162\u20131165. https:\/\/doi.org\/10.1086\/605609","journal-title":"J Infect Dis"},{"issue":"8","key":"9618_CR71","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.syapm.2011.05.002","volume":"34","author":"AG Lindenstrauss","year":"2011","unstructured":"Lindenstrauss AG, Pavlovic M, Bringmann A, Behr J, Ehrmann MA, Vogel RF (2011) Comparison of genotypic and phenotypic cluster analyses of virulence determinants and possible role of CRISPR elements towards their incidence in Enterococcus faecalis and Enterococcus faecium. Syst Appl Microbiol 34(8):553\u2013560. https:\/\/doi.org\/10.1016\/j.syapm.2011.05.002","journal-title":"Syst Appl Microbiol"},{"issue":"1","key":"9618_CR72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2008.06.004","volume":"66","author":"F Lopez","year":"2010","unstructured":"Lopez F, Culebras E, Betriu C, Rodriguez-Avial I, Gomez M, Picazo JJ (2010) Antimicrobial susceptibility and macrolide resistance genes in Enterococcus faecium with reduced susceptibility to quinupristin-dalfopristin: level of quinupristin-dalfopristin resistance is not dependent on erm(B) attenuator region sequence. Diagn Microbiol Infect Dis 66(1):73\u201377. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.06.004","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"9618_CR73","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3947\/ic.2014.46.4.253","volume":"46","author":"S Maraki","year":"2014","unstructured":"Maraki S, Samonis G, Dimopoulou D, Mantadakis E (2014) Susceptibility of glycopeptide-resistant enterococci to linezolid, quinupristin\/dalfopristin, tigecycline and daptomycin in a tertiary Greek hospital. Infect Chemother 46(4):253\u2013256. https:\/\/doi.org\/10.3947\/ic.2014.46.4.253","journal-title":"Infect Chemother"},{"issue":"1","key":"9618_CR74","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/jac\/dkp154","volume":"64","author":"V Mave","year":"2009","unstructured":"Mave V, Garcia-Diaz J, Islam T, Hasbun R (2009) Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid? J Antimicrob Chemother 64(1):175\u2013180. https:\/\/doi.org\/10.1093\/jac\/dkp154","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"9618_CR75","doi-asserted-by":"publisher","first-page":"3923","DOI":"10.1128\/AAC.00192-13","volume":"57","author":"M McLaughlin","year":"2013","unstructured":"McLaughlin M, Malczynski M, Qi C, Barajas G, Radetski J, Zembower T, Scheetz MH (2013) Virulence of vancomycin-resistant Enterococcus faecium according to linezolid resistance and clinical outbreak status. Antimicrob Agents Chemother 57(8):3923\u20133927. https:\/\/doi.org\/10.1128\/AAC.00192-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"9618_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2014.04.002","volume":"17","author":"RE Mendes","year":"2014","unstructured":"Mendes RE, Deshpande LM, Jones RN (2014) Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Drug Resist Updat 17(1\u20132):1\u201312. https:\/\/doi.org\/10.1016\/j.drup.2014.04.002","journal-title":"Drug Resist Updat"},{"issue":"2","key":"9618_CR77","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1128\/AAC.02112-13","volume":"58","author":"RE Mendes","year":"2014","unstructured":"Mendes RE, Flamm RK, Hogan PA, Ross JE, Jones RN (2014) Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States. Antimicrob Agents Chemother 58(2):1243\u20131247. https:\/\/doi.org\/10.1128\/AAC.02112-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"9618_CR78","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1128\/AEM.02150-07","volume":"74","author":"M Millette","year":"2008","unstructured":"Millette M, Cornut G, Dupont C, Shareck F, Archambault D, Lacroix M (2008) Capacity of human nisin- and pediocin-producing lactic acid bacteria to reduce intestinal colonization by vancomycin-resistant enterococci. Appl Environ Microbiol 74(7):1997\u20132003. https:\/\/doi.org\/10.1128\/AEM.02150-07","journal-title":"Appl Environ Microbiol"},{"issue":"8","key":"9618_CR79","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1099\/0022-1317-50-8-695","volume":"50","author":"S Miyazaki","year":"2001","unstructured":"Miyazaki S, Fujikawa T, Kobayashi I, Matsumoto T, Tateda K, Yamaguchi K (2001) Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice. J Med Microbiol 50(8):695\u2013701. https:\/\/doi.org\/10.1099\/0022-1317-50-8-695","journal-title":"J Med Microbiol"},{"issue":"7","key":"9618_CR80","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1345\/aph.1M085","volume":"43","author":"PA Moise","year":"2009","unstructured":"Moise PA, Hershberger E, Amodio-Groton MI, Lamp KC (2009) Safety and clinical outcomes when utilizing high-dose (> or =\u20098\u00a0mg\/kg) daptomycin therapy. Ann Pharmacother 43(7):1211\u20131219. https:\/\/doi.org\/10.1345\/aph.1M085","journal-title":"Ann Pharmacother"},{"issue":"2","key":"9618_CR81","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1128\/AAC.02663-14","volume":"59","author":"D Munch","year":"2015","unstructured":"Munch D, Engels I, Muller A, Reder-Christ K, Falkenstein-Paul H, Bierbaum G, Grein F, Bendas G, Sahl HG, Schneider T (2015) Structural variations of the cell wall precursor lipid II and their influence on binding and activity of the lipoglycopeptide antibiotic oritavancin. Antimicrob Agents Chemother 59(2):772\u2013781. https:\/\/doi.org\/10.1128\/AAC.02663-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"9618_CR82","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200003093421007","volume":"342","author":"BE Murray","year":"2000","unstructured":"Murray BE (2000) Vancomycin-resistant enterococcal infections. N Engl J Med 342(10):710\u2013721. https:\/\/doi.org\/10.1056\/NEJM200003093421007","journal-title":"N Engl J Med"},{"issue":"6","key":"9618_CR83","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1046\/j.1365-2958.2003.03417.x","volume":"47","author":"SR Nallapareddy","year":"2003","unstructured":"Nallapareddy SR, Weinstock GM, Murray BE (2003) Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol 47(6):1733\u20131747","journal-title":"Mol Microbiol"},{"key":"9618_CR84","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/IDR.S54125","volume":"8","author":"T O'Driscoll","year":"2015","unstructured":"O'Driscoll T, Crank CW (2015) Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 8:217\u2013230. https:\/\/doi.org\/10.2147\/IDR.S54125","journal-title":"Infect Drug Resist"},{"issue":"4","key":"9618_CR85","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mbo3.363","volume":"5","author":"C Oppegard","year":"2016","unstructured":"Oppegard C, Kjos M, Veening JW, Nissen-Meyer J, Kristensen T (2016) A putative amino acid transporter determines sensitivity to the two-peptide bacteriocin plantaricin JK. Microbiologyopen 5(4):700\u2013708. https:\/\/doi.org\/10.1002\/mbo3.363","journal-title":"Microbiologyopen"},{"issue":"17","key":"9618_CR86","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1128\/AEM.01094-16","volume":"82","author":"KV Ovchinnikov","year":"2016","unstructured":"Ovchinnikov KV, Chi H, Mehmeti I, Holo H, Nes IF, Diep DB (2016) Novel group of leaderless multipeptide bacteriocins from Gram-positive bacteria. Appl Environ Microbiol 82(17):5216\u20135224. https:\/\/doi.org\/10.1128\/AEM.01094-16","journal-title":"Appl Environ Microbiol"},{"key":"9618_CR87","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3389\/fmicb.2017.00774","volume":"8","author":"KV Ovchinnikov","year":"2017","unstructured":"Ovchinnikov KV, Kristiansen PE, Straume D, Jensen MS, Aleksandrzak-Piekarczyk T, Nes IF, Diep DB (2017) The leaderless bacteriocin enterocin K1 is highly potent against Enterococcus faecium: a study on structure, target spectrum and receptor. Front Microbiol 8:774. https:\/\/doi.org\/10.3389\/fmicb.2017.00774","journal-title":"Front Microbiol"},{"issue":"34","key":"9618_CR88","doi-asserted-by":"publisher","first-page":"23838","DOI":"10.1074\/jbc.M114.579698","volume":"289","author":"KV Ovchinnikov","year":"2014","unstructured":"Ovchinnikov KV, Kristiansen PE, Uzelac G, Topisirovic L, Kojic M, Nissen-Meyer J, Nes IF, Diep DB (2014) Defining the structure and receptor binding domain of the leaderless bacteriocin LsbB. J Biol Chem 289(34):23838\u201323845. https:\/\/doi.org\/10.1074\/jbc.M114.579698","journal-title":"J Biol Chem"},{"issue":"5","key":"9618_CR89","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.mib.2010.08.004","volume":"13","author":"KL Palmer","year":"2010","unstructured":"Palmer KL, Kos VN, Gilmore MS (2010) Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr Opin Microbiol 13(5):632\u2013639. https:\/\/doi.org\/10.1016\/j.mib.2010.08.004","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"9618_CR90","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/1060028014556879","volume":"49","author":"R Patel","year":"2015","unstructured":"Patel R, Gallagher JC (2015) Vancomycin-resistant enterococcal bacteremia pharmacotherapy. Ann Pharmacother 49(1):69\u201385. https:\/\/doi.org\/10.1177\/1060028014556879","journal-title":"Ann Pharmacother"},{"issue":"5","key":"9618_CR91","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jmb.2009.06.064","volume":"392","author":"GJ Patti","year":"2009","unstructured":"Patti GJ, Kim SJ, Yu TY, Dietrich E, Tanaka KS, Parr TR Jr, Far AR, Schaefer J (2009) Vancomycin and oritavancin have different modes of action in Enterococcus faecium. J Mol Biol 392(5):1178\u20131191. https:\/\/doi.org\/10.1016\/j.jmb.2009.06.064","journal-title":"J Mol Biol"},{"issue":"Suppl 1","key":"9618_CR92","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1475-2859-13-S1-S3","volume":"13","author":"RH Perez","year":"2014","unstructured":"Perez RH, Zendo T, Sonomoto K (2014) Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications. Microb Cell Fact 13(Suppl 1):S3. https:\/\/doi.org\/10.1186\/1475-2859-13-S1-S3","journal-title":"Microb Cell Fact"},{"issue":"10","key":"9618_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186415","volume":"12","author":"U Phumisantiphong","year":"2017","unstructured":"Phumisantiphong U, Siripanichgon K, Reamtong O, Diraphat P (2017) A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci. PLoS One 12(10):e0186415. https:\/\/doi.org\/10.1371\/journal.pone.0186415","journal-title":"PLoS One"},{"issue":"1","key":"9618_CR94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1017\/ice.2015.228","volume":"37","author":"C Prematunge","year":"2016","unstructured":"Prematunge C, MacDougall C, Johnstone J, Adomako K, Lam F, Robertson J, Garber G (2016) VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37(1):26\u201335. https:\/\/doi.org\/10.1017\/ice.2015.228","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"9618_CR95","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.femsle.2004.11.006","volume":"242","author":"NJ Pultz","year":"2005","unstructured":"Pultz NJ, Shankar N, Baghdayan AS, Donskey CJ (2005) Enterococcal surface protein Esp does not facilitate intestinal colonization or translocation of Enterococcus faecalis in clindamycin-treated mice. FEMS Microbiol Lett 242(2):217\u2013219. https:\/\/doi.org\/10.1016\/j.femsle.2004.11.006","journal-title":"FEMS Microbiol Lett"},{"issue":"3","key":"9618_CR96","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00284-005-0244-2","volume":"52","author":"NJ Pultz","year":"2006","unstructured":"Pultz NJ, Vesterlund S, Ouwehand AC, Donskey CJ (2006) Adhesion of vancomycin-resistant enterococcus to human intestinal mucus. Curr Microbiol 52(3):221\u2013224. https:\/\/doi.org\/10.1007\/s00284-005-0244-2","journal-title":"Curr Microbiol"},{"issue":"9","key":"9618_CR97","doi-asserted-by":"publisher","first-page":"DC01","DOI":"10.7860\/JCDR\/2017\/25988.10548","volume":"11","author":"G Purohit","year":"2017","unstructured":"Purohit G, Gaind R, Dawar R, Verma PK, Aggarwal KC, Sardana R, Deb M (2017) Characterization of vancomycin resistant enterococci in hospitalized patients and role of gut colonization. J Clin Diagn Res 11(9):DC01\u2013DC05. https:\/\/doi.org\/10.7860\/JCDR\/2017\/25988.10548","journal-title":"J Clin Diagn Res"},{"issue":"9","key":"9618_CR98","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1128\/AAC.48.9.3583-3585.2004","volume":"48","author":"II Raad","year":"2004","unstructured":"Raad II, Hanna HA, Hachem RY, Dvorak T, Arbuckle RB, Chaiban G, Rice LB (2004) Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob Agents Chemother 48(9):3583\u20133585. https:\/\/doi.org\/10.1128\/AAC.48.9.3583-3585.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"9618_CR99","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.micro.55.1.591","volume":"55","author":"TL Raivio","year":"2001","unstructured":"Raivio TL, Silhavy TJ (2001) Periplasmic stress and ECF sigma factors. Annu Rev Microbiol 55:591\u2013624. https:\/\/doi.org\/10.1146\/annurev.micro.55.1.591","journal-title":"Annu Rev Microbiol"},{"key":"9618_CR100","doi-asserted-by":"publisher","unstructured":"Ramu R, Shirahatti PS, Devi AT, Prasad A, J K, M S L, F Z, B LD, M N N (2015) Bacteriocins and their applications in food preservation. Crit Rev Food Sci Nutr 0. https:\/\/doi.org\/10.1080\/10408398.2015.1020918","DOI":"10.1080\/10408398.2015.1020918"},{"issue":"5","key":"9618_CR101","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.syapm.2012.05.004","volume":"35","author":"IU Rathnayake","year":"2012","unstructured":"Rathnayake IU, Hargreaves M, Huygens F (2012) Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates. Syst Appl Microbiol 35(5):326\u2013333. https:\/\/doi.org\/10.1016\/j.syapm.2012.05.004","journal-title":"Syst Appl Microbiol"},{"key":"9618_CR102","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.micro.56.012302.161024","volume":"56","author":"MA Riley","year":"2002","unstructured":"Riley MA, Wertz JE (2002) Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 56:117\u2013137. https:\/\/doi.org\/10.1146\/annurev.micro.56.012302.161024","journal-title":"Annu Rev Microbiol"},{"issue":"5","key":"9618_CR103","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40262-017-0601-x","volume":"57","author":"C Roger","year":"2018","unstructured":"Roger C, Roberts JA, Muller L (2018) Clinical pharmacokinetics and pharmacodynamics of oxazolidinones. Clin Pharmacokinet 57(5):559\u2013575. https:\/\/doi.org\/10.1007\/s40262-017-0601-x","journal-title":"Clin Pharmacokinet"},{"key":"9618_CR104","doi-asserted-by":"publisher","first-page":"958469","DOI":"10.1155\/2014\/958469","volume":"2014","author":"RG Rosa","year":"2014","unstructured":"Rosa RG, Schwarzbold AV, Dos Santos RP, Turra EE, Machado DP, Goldani LZ (2014) Vancomycin-resistant Enterococcus faecium bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome. Biomed Res Int 2014:958469. https:\/\/doi.org\/10.1155\/2014\/958469","journal-title":"Biomed Res Int"},{"issue":"6","key":"9618_CR105","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3109\/10428194.2013.842983","volume":"55","author":"AE Rosko","year":"2014","unstructured":"Rosko AE, Corriveau M, Suwantarat N, Arfons L, Treasure M, Parker P, Jacobs M, Fu P, Salata R, Lazarus HM (2014) Vancomycin-resistant enterococci infection: not just for the transplanted. Leuk Lymphoma 55(6):1320\u20131325. https:\/\/doi.org\/10.3109\/10428194.2013.842983","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"9618_CR106","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ijantimicag.2014.01.018","volume":"43","author":"HS Sader","year":"2014","unstructured":"Sader HS, Farrell DJ, Flamm RK, Jones RN (2014) Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a worldwide surveillance programme (2005\u20132012). Int J Antimicrob Agents 43(5):465\u2013469. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.01.018","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"9618_CR107","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.diagmicrobio.2009.06.016","volume":"65","author":"HS Sader","year":"2009","unstructured":"Sader HS, Jones RN (2009) Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin surveillance program (2007\u20132008). Diagn Microbiol Infect Dis 65(2):158\u2013162. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.06.016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"9618_CR108","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.diagmicrobio.2014.08.011","volume":"81","author":"DF Sahm","year":"2015","unstructured":"Sahm DF, Deane J, Bien PA, Locke JB, Zuill DE, Shaw KJ, Bartizal KF (2015) Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe. Diagn Microbiol Infect Dis 81(2):112\u2013118. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2014.08.011","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"9618_CR109","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/AAC.43.1.115","volume":"43","author":"A Saleh-Mghir","year":"1999","unstructured":"Saleh-Mghir A, Lefort A, Petegnief Y, Dautrey S, Vallois JM, Le Guludec D, Carbon C, Fantin B (1999) Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 43(1):115\u2013120","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"9618_CR110","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1086\/502271","volume":"24","author":"CD Salgado","year":"2003","unstructured":"Salgado CD, Farr BM (2003) Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 24(9):690\u2013698. https:\/\/doi.org\/10.1086\/502271","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"9618_CR111","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4161\/viru.1.4.11966","volume":"1","author":"J Sillanpaa","year":"2010","unstructured":"Sillanpaa J, Nallapareddy SR, Singh KV, Prakash VP, Fothergill T, Ton-That H, Murray BE (2010) Characterization of the ebp(fm) pilus-encoding operon of Enterococcus faecium and its role in biofilm formation and virulence in a murine model of urinary tract infection. Virulence 1(4):236\u2013246","journal-title":"Virulence"},{"key":"9618_CR112","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fmicb.2018.00594","volume":"9","author":"CCG Silva","year":"2018","unstructured":"Silva CCG, Silva SPM, Ribeiro SC (2018) Application of bacteriocins and protective cultures in dairy food preservation. Front Microbiol 9:594. https:\/\/doi.org\/10.3389\/fmicb.2018.00594","journal-title":"Front Microbiol"},{"issue":"10","key":"9618_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076844","volume":"8","author":"AP Singh","year":"2013","unstructured":"Singh AP, Prabha V, Rishi P (2013) Value addition in the efficacy of conventional antibiotics by nisin against Salmonella. PLoS One 8(10):e76844. https:\/\/doi.org\/10.1371\/journal.pone.0076844","journal-title":"PLoS One"},{"issue":"1","key":"9618_CR114","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1517\/14712598.2013.844227","volume":"14","author":"JD Steckbeck","year":"2014","unstructured":"Steckbeck JD, Deslouches B, Montelaro RC (2014) Antimicrobial peptides: new drugs for bad bugs? Expert Opin Biol Ther 14(1):11\u201314. https:\/\/doi.org\/10.1517\/14712598.2013.844227","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"9618_CR115","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/502408","volume":"25","author":"U Stiefel","year":"2004","unstructured":"Stiefel U, Pultz NJ, Helfand MS, Donskey CJ (2004) Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice. Infect Control Hosp Epidemiol 25(5):373\u2013379. https:\/\/doi.org\/10.1086\/502408","journal-title":"Infect Control Hosp Epidemiol"},{"key":"9618_CR116","unstructured":"Surveillance of antimicrobial resistance in Europe 2016. (2017). Surveillance of antimicrobial resistance in Europe 2016"},{"issue":"5","key":"9618_CR117","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.ijantimicag.2019.03.009","volume":"53","author":"VM Thomas","year":"2019","unstructured":"Thomas VM, Brown RM, Ashcraft DS, Pankey GA (2019) Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Int J Antimicrob Agents 53(5):663\u2013668. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.03.009","journal-title":"Int J Antimicrob Agents"},{"key":"9618_CR118","doi-asserted-by":"publisher","unstructured":"Tran TT, Panesso D, Mishra NN, Mileykovskaya E, Guan Z, Munita JM, Reyes J, Diaz L, Weinstock GM, Murray BE, Shamoo Y, Dowhan W, Bayer AS, Arias CA (2013) Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids. MBio 4(4). https:\/\/doi.org\/10.1128\/mBio.00281-13","DOI":"10.1128\/mBio.00281-13"},{"issue":"3","key":"9618_CR119","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jhm.994","volume":"7","author":"JD Twilla","year":"2012","unstructured":"Twilla JD, Finch CK, Usery JB, Gelfand MS, Hudson JQ, Broyles JE (2012) Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin. J Hosp Med 7(3):243\u2013248. https:\/\/doi.org\/10.1002\/jhm.994","journal-title":"J Hosp Med"},{"issue":"12","key":"9618_CR120","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1172\/Jci43918","volume":"120","author":"C Ubeda","year":"2010","unstructured":"Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND, van den Brink MRM, Kamboj M, Pamer EG (2010) Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest 120(12):4332\u20134341. https:\/\/doi.org\/10.1172\/Jci43918","journal-title":"J Clin Invest"},{"issue":"4","key":"9618_CR121","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2672.2012.05241.x","volume":"112","author":"AD van Staden","year":"2012","unstructured":"van Staden AD, Brand AM, Dicks LM (2012) Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo. J Appl Microbiol 112(4):831\u2013840. https:\/\/doi.org\/10.1111\/j.1365-2672.2012.05241.x","journal-title":"J Appl Microbiol"},{"issue":"7","key":"9618_CR122","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1128\/AAC.02938-15","volume":"60","author":"AP van Staden","year":"2016","unstructured":"van Staden AP, Heunis T, Smith C, Deane S, Dicks LM (2016) Efficacy of lantibiotic treatment of Staphylococcus aureus-induced skin infections, monitored by in vivo bioluminescent imaging. Antimicrob Agents Chemother 60(7):3948\u20133955. https:\/\/doi.org\/10.1128\/AAC.02938-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"9618_CR123","doi-asserted-by":"publisher","first-page":"484","DOI":"10.7326\/0003-4819-135-7-200110020-00007","volume":"135","author":"EN Vergis","year":"2001","unstructured":"Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR (2001) Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med 135(7):484\u2013492","journal-title":"Ann Intern Med"},{"issue":"6","key":"9618_CR124","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3201\/eid1106.041204","volume":"11","author":"RJ Willems","year":"2005","unstructured":"Willems RJ, Top J, van Santen M, Robinson DA, Coque TM, Baquero F, Grundmann H, Bonten MJ (2005) Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 11(6):821\u2013828. https:\/\/doi.org\/10.3201\/eid1106.041204","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"9618_CR125","doi-asserted-by":"publisher","first-page":"95","DOI":"10.33073\/pjm-2012-012","volume":"61","author":"KI Wolska","year":"2012","unstructured":"Wolska KI, Grzes K, Kurek A (2012) Synergy between novel antimicrobials and conventional antibiotics or bacteriocins. Pol J Microbiol 61(2):95\u2013104","journal-title":"Pol J Microbiol"},{"key":"9618_CR126","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3389\/fmicb.2014.00241","volume":"5","author":"SC Yang","year":"2014","unstructured":"Yang SC, Lin CH, Sung CT, Fang JY (2014) Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol 5:241. https:\/\/doi.org\/10.3389\/fmicb.2014.00241","journal-title":"Front Microbiol"},{"issue":"5","key":"9618_CR127","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/phar.1922","volume":"37","author":"J Yim","year":"2017","unstructured":"Yim J, Smith JR, Rybak MJ (2017) Role of combination antimicrobial therapy for vancomycin-resistant Enterococcus faecium infections: review of the current evidence. Pharmacotherapy 37(5):579\u2013592. https:\/\/doi.org\/10.1002\/phar.1922","journal-title":"Pharmacotherapy"},{"issue":"10","key":"9618_CR128","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/cid\/ciw110","volume":"62","author":"EJ Zasowski","year":"2016","unstructured":"Zasowski EJ, Claeys KC, Lagnf AM, Davis SL, Rybak MJ (2016) Time is of the essence: the impact of delayed antibiotic therapy on patient outcomes in hospital-onset enterococcal bloodstream infections. Clin Infect Dis 62(10):1242\u20131250. https:\/\/doi.org\/10.1093\/cid\/ciw110","journal-title":"Clin Infect Dis"},{"key":"9618_CR129","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fcell.2016.00007","volume":"4","author":"L Zhou","year":"2016","unstructured":"Zhou L, van Heel AJ, Montalban-Lopez M, Kuipers OP (2016) Potentiating the activity of nisin against Escherichia coli. Front Cell Dev Biol 4:7. https:\/\/doi.org\/10.3389\/fcell.2016.00007","journal-title":"Front Cell Dev Biol"}],"updated-by":[{"DOI":"10.1007\/s12602-021-09873-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000}}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-019-09618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-019-09618-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-019-09618-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T06:10:00Z","timestamp":1637820600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-019-09618-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["9618"],"URL":"https:\/\/doi.org\/10.1007\/s12602-019-09618-6","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12602-021-09873-6","asserted-by":"object"}]},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"22 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2021","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12602-021-09873-6","URL":"https:\/\/doi.org\/10.1007\/s12602-021-09873-6","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}